Summary.
Several 4-aminobicyclo[2.2.2]octan-2-ones and -ols were synthesized using different pathways. The new compounds were investigated for their activity against Trypanosoma b. rhodesiense, the causative organism of East African sleeping sickness and Plasmodium falciparum the protozoan parasite which causes Malaria tropica. The results are compared to the activities of known compounds and the influence of the substitution of the bicyclo[2.2.2]octane skeleton on the biological activities is discussed.
Similar content being viewed by others
References
C Burri S Nkunku A Merolle T Smith J Blum R Brun (2000) Lancet 355 1419 Occurrence Handle10.1016/S0140-6736(00)02141-3 Occurrence Handle1:CAS:528:DC%2BD3cXjtVertbg%3D
MP Barrett RJS Burchmore A Stich JO Lazzari AC Frasch JJ Cazzulo S Krishna (2003) Lancet 362 1469 Occurrence Handle10.1016/S0140-6736(03)14694-6
FW Jennings J Rodgers B Bradley G Gettinby PGE Kennedy M Murray (2002) Parasit Int 51 381 Occurrence Handle1:CAS:528:DC%2BD38XosFequ74%3D
World Health Organization (1999) Human African Trypanosomiasis Treatment and Drug Resistance Network. Report of the first meeting. Geneva, World Health Organization, 14–15 April 1999, WHO/CDS/CSR/EDC/99.5. WHO: Geneva
EC Agbo PAO Majiwa P Büscher E Claassen MFW te Pas (2003) Trends in Microbiology 11 329 Occurrence Handle10.1016/S0966-842X(03)00151-3
VS Moorthy MF Good AS Hill (2004) Lancet 363 156 Occurrence Handle10.1016/S0140-6736(03)15267-1
A Attaran KI Barnes C Curtis U d’ Alessandro CI Fanello MR Galinski G Kokwaro S Looareesuwan M Makanga TK Mutabingwa A Talisuna JF Trape WM Watkins (2004) Lancet 363 240 Occurrence Handle10.1016/S0140-6736(03)15330-5
L Loutan (2003) Int J Antimicrob Agents 21 163
FC Tanser D le Suer (2002) Int J Health Geogr 1 4 Occurrence Handle10.1186/1476-072X-1-4
SR Meshnick (2002) Int J Parasit 32 1660 Occurrence Handle10.1016/S0020-7519(02)00194-7
R Weis R Brun R Saf W Seebacher (2003) Monatsh Chem 134 1019 Occurrence Handle1:CAS:528:DC%2BD3sXksV2hsr8%3D
W Seebacher M Kaiser R Brun R Saf R Weis (2005) Monatsh Chem 136 625 Occurrence Handle10.1007/s00706-004-0264-9 Occurrence Handle1:CAS:528:DC%2BD2MXisl2qtro%3D
JA Adamcik EJ Miklasiewicz (1963) J Org Chem 28 336 Occurrence Handle1:CAS:528:DyaF3sXks1ehtA%3D%3D
HA Bruson TW Riener (1942) J Am Chem Soc 64 2850 Occurrence Handle1:CAS:528:DyaH3sXotlCm
Colonge J, Vuillemet R (1961) Bull Soc chim Fr: 2235
Ahmed SA, Hickmott PW (1979) J Chem Soc Perkin I: 2180
R Weis K Schweiger W Seebacher F Belaj (1998) Tetrahedron 54 14015 Occurrence Handle10.1016/S0040-4020(98)00864-3 Occurrence Handle1:CAS:528:DyaK1cXntFSmsr0%3D
D Weiss S Hobe R Beckert D Klemm (1990) J Prak Chem 332 367 Occurrence Handle1:CAS:528:DyaK3cXmtlWktL0%3D
W Seebacher R Brun R Weis (2004) Eur J Pharm Sci 21 225 Occurrence Handle1:CAS:528:DC%2BD2cXptFWrsw%3D%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seebacher, W., Berger, H., Kaiser, M. et al. Structural Requirements for the Antiprotozoal Activity of 4-Aminobicyclo[2.2.2]octan-2-ols. Monatsh. Chem. 137, 471–482 (2006). https://doi.org/10.1007/s00706-006-0455-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-006-0455-7